MedTrace Logo

Preload and Autonomic Responses With Cardiac Neuromodulation Therapy (CNT) (CS-06)

NCT04463121 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-09-19

No results posted yet for this study

Summary

This investigation will evaluate the effect of RV pacing lead position on cardiac function and the modulation of the autonomic nervous system with Cardiac Neuromodulation Therapy (CNT) pacing signals. The study will be performed acutely prior to a pacemaker implant.

Conditions

  • Bradycardia
  • Hypertension, Systolic

Interventions

DEVICE

Moderato IPG's CNT pacing signals

Assesment of cardiac function and sympatheric activity will be obtained simultaneously

DEVICE

CD Leycom Pressure/Volume Combination Catheters

Simultaneous recording of the Pressure, Volume measurements and ECG signals will be done for constant monitoring of intra-ventricular pressure and volume.

Sponsors & Collaborators

  • CD Leycom

    collaborator UNKNOWN

  • BackBeat Medical Inc

    lead INDUSTRY

Principal Investigators

  • Petr Neuzil, MD, PhD · Na Homolce Hospital

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-07
Primary Completion
2023-03-31
Completion
2023-07-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04463121 on ClinicalTrials.gov